Evidence map›Paper›PMID 41884835›Full record

ArticleFrontiers in immunology2026

Editorial: Vaccines and molecular therapeutics for tuberculosis.

Suraj B Sable, Vijayakumar Velu, Andreas Kupz

Abstract readEditorial
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Suraj B SableIndepent Researcher, Atlanta, GA, United States.
Vijayakumar VeluDivision of Pathology and Laboratory Medicine, Emory University School of Medicine and Division of Microbiology and Immunology, Emory National Primate Research Center, Emory Vaccine Center,, Atlanta, GA, United States.
Andreas KupzAustralian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD, Australia.

Funding

Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Jeffrey M Collins · 2022 to 2026
$5.8M
NIAID NIH HHS P30 AI168386
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BCG - Bacille Calmette-Guérin vaccinecorrelates of protectiongranuloma topographyhost-directed therapiesmetabolism-linked antigenicity and immunogenicityMycobacterium tuberculosis“site-aware” tuberculosis vaccinationvaccine platform and delivery technologies

Identifiers

PMID41884835
PMCPMC13010159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.